Cargando…

OAS-RNase L innate immune pathway mediates the cytotoxicity of a DNA-demethylating drug

Drugs that reverse epigenetic silencing, such as the DNA methyltransferase inhibitor (DNMTi) 5-azacytidine (AZA), have profound effects on transcription and tumor cell survival. AZA is an approved drug for myelodysplastic syndromes and acute myeloid leukemia, and is under investigation for different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Banerjee, Shuvojit, Gusho, Elona, Gaughan, Christina, Dong, Beihua, Gu, Xiaorong, Holvey-Bates, Elise, Talukdar, Manisha, Li, Yize, Weiss, Susan R., Sicheri, Frank, Saunthararajah, Yogen, Stark, George R., Silverman, Robert H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2019
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6421468/ https://www.ncbi.nlm.nih.gov/pubmed/30814222 http://dx.doi.org/10.1073/pnas.1815071116

Ejemplares similares

New advances in our understanding of the “unique” RNase L in host pathogen interaction and immune signaling
por: Gusho, Elona, et al.
Publicado: (2020)

A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency
por: Daou, Salima, et al.
Publicado: (2020)

108 : Preventing activation of the IFN inducible OAS-RNase L pathway by A-kinase anchoring protein 7 (AKAP7)
por: Gusho, Elona, et al.
Publicado: (2013)

RNase L is a negative regulator of cell migration
por: Banerjee, Shuvojit, et al.
Publicado: (2015)

Activation of RNase L in Egyptian Rousette Bat-Derived RoNi/7 Cells Is Dependent Primarily on OAS3 and Independent of MAVS Signaling
por: Li, Yize, et al.
Publicado: (2019)

Murine AKAP7 Has a 2′,5′-Phosphodiesterase Domain That Can Complement an Inactive Murine Coronavirus ns2 Gene
por: Gusho, Elona, et al.
Publicado: (2014)

Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line
por: Li, Yize, et al.
Publicado: (2017)

Human Papillomaviruses Target the DNA Damage Repair and Innate Immune Response Pathways to Allow for Persistent Infection
por: Gusho, Elona, et al.
Publicado: (2021)

Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity
por: Huang, Hao, et al.
Publicado: (2014)

Human papillomaviruses sensitize cells to DNA damage induced apoptosis by targeting the innate immune sensor cGAS
por: Gusho, Elona, et al.
Publicado: (2022)

Inhibition of the OAS/RNase L pathway by viruses
por: Drappier, Melissa, et al.
Publicado: (2015)

Initiation of a ZAKα-dependent Ribotoxic Stress Response by the Innate Immunity Endoribonuclease RNase L
por: Xi, Jiajia, et al.
Publicado: (2023)

Cell-Type-Specific Effects of RNase L on Viral Induction of Beta Interferon
por: Banerjee, Shuvojit, et al.
Publicado: (2014)

Specificity and Mechanism of Coronavirus, Rotavirus, and Mammalian Two-Histidine Phosphoesterases That Antagonize Antiviral Innate Immunity
por: Asthana, Abhishek, et al.
Publicado: (2021)

Recurrent Viral Capture of Cellular Phosphodiesterases that Antagonize OAS-RNase L
por: Goldstein, Stephen A., et al.
Publicado: (2023)

Targeting sickle cell disease root-cause pathophysiology with small molecules
por: Saunthararajah, Yogen
Publicado: (2019)

Mysteries of partial dihydroorotate dehydrogenase inhibition and leukemia terminal differentiation
por: Saunthararajah, Yogen
Publicado: (2020)

Inborn errors of OAS–RNase L in SARS-CoV-2–related multisystem inflammatory syndrome in children
por: Lee, Danyel, et al.
Publicado: (2023)

RNase L restricts the mobility of engineered retrotransposons in cultured human cells
por: Zhang, Ao, et al.
Publicado: (2014)

O030 Evasion of the OAS-RNase L pathway by murine coronavirus ns2 protein is required for viral replication and hepatitis
por: Jha, B.K., et al.
Publicado: (2012)

Dom34 mediates targeting of exogenous RNA in the antiviral OAS/RNase L pathway
por: Nogimori, Takuto, et al.
Publicado: (2019)

Antagonism of the Interferon-Induced OAS-RNase L Pathway by Murine Coronavirus ns2 Protein Is Required for Virus Replication and Liver Pathology
por: Zhao, Ling, et al.
Publicado: (2012)

Overexpression of the Transcription Factor Sp1 Activates the OAS-RNAse L-RIG-I Pathway
por: Dupuis-Maurin, Valéryane, et al.
Publicado: (2015)

Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through Direct Inhibition of RNase L
por: Sorgeloos, Frédéric, et al.
Publicado: (2013)

Severe pyoderma gangrenosum caused by myelodysplastic syndrome successfully treated with decitabine administered by a noncytotoxic regimen
por: Saleh, Mostafa F. M., et al.
Publicado: (2017)

5-aza-2′,2′-Difluroro Deoxycytidine (NUC013): A Novel Nucleoside DNA Methyl Transferase Inhibitor and Ribonucleotide Reductase Inhibitor for the Treatment of Cancer
por: Daifuku, Richard, et al.
Publicado: (2017)

Molecular Mechanisms for the Adaptive Switching Between the OAS/RNase L and OASL/RIG-I Pathways in Birds and Mammals
por: Rong, Enguang, et al.
Publicado: (2018)

Differentiation therapy and the mechanisms that terminate cancer cell proliferation without harming normal cells
por: Enane, Francis O., et al.
Publicado: (2018)

RNase 7 participates in cutaneous innate control of Corynebacterium amycolatum
por: Walter, Stephanie, et al.
Publicado: (2017)

The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response
por: Ezelle, Heather J., et al.
Publicado: (2016)

The Ribonuclease A Superfamily in Humans: Canonical RNases as the Buttress of Innate Immunity
por: Koczera, Patrick, et al.
Publicado: (2016)

High cytidine deaminase expression in the liver provides sanctuary for cancer cells from decitabine treatment effects
por: Ebrahem, Quteba, et al.
Publicado: (2012)

Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation
por: Thornbrough, Joshua M., et al.
Publicado: (2016)

The role of ZAP and OAS3/RNAseL pathways in the attenuation of an RNA virus with elevated frequencies of CpG and UpA dinucleotides
por: Odon, Valerie, et al.
Publicado: (2019)

Prognostic characterization of OAS1/OAS2/OAS3/OASL in breast cancer
por: Zhang, Yujie, et al.
Publicado: (2020)

Putting the brakes on the unfolded protein response
por: Sicheri, Frank, et al.
Publicado: (2011)

Decitabine Suspends Human CD34(+) Cell Differentiation and Proliferation during Lentiviral Transduction
por: Uchida, Naoya, et al.
Publicado: (2014)

Clinical Trials Assessing Hypomethylating Agents Combined with Other Therapies: Causes for Failure and Potential Solutions
por: Zavras, Phaedon D., et al.
Publicado: (2021)

DNA Methyltransferase 1 Targeting Using Guadecitabine Inhibits Prostate Cancer Growth by an Apoptosis-Independent Pathway
por: Karan, Dev, et al.
Publicado: (2023)

On the silicon diodes, types OA 200 and OA 202
por: Mulder, P B
Publicado: (1958)

Cannot write session to /tmp/vufind_sessions/sess_ls5nufokgahv2a7i4qoscc2a8p